Stockholm - Delayed Quote SEK
Biotage AB (publ) (BIOT.ST)
At close: October 25 at 5:29 PM GMT+2
Breakdown
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Total Revenue
2,117,000.00
1,566,000.00
1,232,000.00
1,092,000.00
1,101,373.00
Cost of Revenue
794,000.00
618,000.00
477,000.00
426,000.00
415,963.00
Gross Profit
1,323,000.00
948,000.00
755,000.00
667,000.00
685,410.00
Operating Expense
988,000.00
656,000.00
499,000.00
480,000.00
479,699.00
Operating Income
335,000.00
292,000.00
256,000.00
187,000.00
205,711.00
Net Non Operating Interest Income Expense
-44,000.00
-3,000.00
-3,000.00
-3,000.00
-2,172.00
Pretax Income
327,000.00
348,000.00
269,000.00
223,000.00
211,992.00
Tax Provision
70,000.00
80,000.00
64,000.00
47,000.00
25,172.00
Net Income Common Stockholders
257,000.00
268,000.00
205,000.00
175,000.00
186,820.00
Diluted NI Available to Com Stockholders
257,000.00
268,000.00
205,000.00
175,000.00
186,820.00
Basic EPS
3.30
4.06
3.13
2.69
2.87
Diluted EPS
3.29
4.04
3.13
2.69
2.87
Basic Average Shares
80,018.46
65,983.78
65,355.24
65,201.78
65,182.13
Diluted Average Shares
80,078.54
66,184.32
65,464.81
65,208.52
65,182.13
Total Operating Income as Reported
350,000.00
327,000.00
271,000.00
206,000.00
208,120.00
Total Expenses
1,782,000.00
1,274,000.00
976,000.00
906,000.00
895,662.00
Net Income from Continuing & Discontinued Operation
257,000.00
268,000.00
205,000.00
175,000.00
186,820.00
Normalized Income
249,926.61
242,590.00
197,400.00
156,112.00
186,820.00
Interest Income
--
2,000.00
--
--
765.00
Interest Expense
--
5,000.00
3,000.00
3,000.00
2,860.00
Net Interest Income
-44,000.00
-3,000.00
-3,000.00
-3,000.00
-2,172.00
EBIT
352,000.00
353,000.00
272,000.00
226,000.00
214,852.00
EBITDA
533,000.00
454,000.00
347,000.00
300,000.00
289,224.00
Reconciled Cost of Revenue
794,000.00
618,000.00
477,000.00
426,000.00
415,963.00
Reconciled Depreciation
181,000.00
101,000.00
75,000.00
74,000.00
74,372.00
Net Income from Continuing Operation Net Minority Interest
257,000.00
268,000.00
205,000.00
175,000.00
186,820.00
Total Unusual Items Excluding Goodwill
9,000.00
33,000.00
10,000.00
24,000.00
--
Total Unusual Items
9,000.00
33,000.00
10,000.00
24,000.00
--
Normalized EBITDA
524,000.00
421,000.00
337,000.00
276,000.00
289,224.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
1,926.61
7,590.00
2,400.00
5,112.00
--
12/31/2019 - 6/30/2000
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
SKAN.SW SKAN Group AG
77.60
-0.39%
DIM.PA Sartorius Stedim Biotech S.A.
188.80
-1.87%
COLO-B.CO Coloplast A/S
883.80
-1.45%
CTEC.L ConvaTec Group PLC
219.00
-0.90%
ALIF-B.ST AddLife AB (publ)
135.10
-1.60%
BONEX.ST Bonesupport Holding AB (publ)
340.00
-0.12%
GXI.DE Gerresheimer AG
82.10
-2.55%
TECN.SW Tecan Group AG
224.40
-1.75%
STMN.SW Straumann Holding AG
126.70
-1.29%
LMAT LeMaitre Vascular, Inc.
85.64
-1.09%